CRLSIPO•prnewswire•
Caris Life Sciences Announces Pricing of Initial Public Offering
Sentiment:Positive (80)
Summary
IRVING, Texas, June 17, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the pricing of its initial public offering of 23,529,412 shares of its common stock, at a public...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 18, 2025 by prnewswire